Intestinal Microbiota of Patients Hospitalized With Sars-CoV-2

Intestinal Microbiota of Patients Hospitalized With Sars-CoV-2

The study investigators hypothesize that SARS-Cov2 infection alters the composition of the digestive microbiota and its functionality, resulting in changes in intestinal permeability and consequently in microbial digestive translocation. These changes may correlate with the magnitude of the SARS-CoV-2 viral load in the gastrointestinal tract and may have an impact on the clinical manifestations and evolvability of COVID-19.

Inclusion Criteria:

• patient hospitalized at in Nimes University hospital
• Infection with SARS-CoV-2 confirmed by RT-PCR
• The patient must have signed the consent form
• The patient must be a member or beneficiary of a health insurance plan

Exclusion Criteria:

• The subject is participating in an interventional study susceptible to modify the intestinal microbiota, or is in a period of exclusion determined by a previous study
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship
• Patient with a chronic digestive pathology or having been operated in the previous year or having enteral nutrition or having had bariatric surgery
• Patient is pregnant, parturient or breastfeeding